AR003137A1 - Una composicion farmaceutica para tratar la leucemia - Google Patents
Una composicion farmaceutica para tratar la leucemiaInfo
- Publication number
- AR003137A1 AR003137A1 ARP960103043A AR10304396A AR003137A1 AR 003137 A1 AR003137 A1 AR 003137A1 AR P960103043 A ARP960103043 A AR P960103043A AR 10304396 A AR10304396 A AR 10304396A AR 003137 A1 AR003137 A1 AR 003137A1
- Authority
- AR
- Argentina
- Prior art keywords
- carbon atoms
- less
- hydrogen
- pharmaceutical composition
- treat leukemia
- Prior art date
Links
- 208000032839 leukemia Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- KDDQRKBRJSGMQE-UHFFFAOYSA-N 4-thiazolyl Chemical group [C]1=CSC=N1 KDDQRKBRJSGMQE-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 230000000855 fungicidal effect Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- -1 nitro, methyl Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47381795A | 1995-06-07 | 1995-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR003137A1 true AR003137A1 (es) | 1998-07-08 |
Family
ID=23881113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960103043A AR003137A1 (es) | 1995-06-07 | 1996-06-07 | Una composicion farmaceutica para tratar la leucemia |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0831816A1 (pt) |
| JP (1) | JPH11506732A (pt) |
| KR (1) | KR19990022617A (pt) |
| CN (1) | CN1186433A (pt) |
| AR (1) | AR003137A1 (pt) |
| AU (1) | AU717382B2 (pt) |
| BR (1) | BR9608730A (pt) |
| CA (1) | CA2223435A1 (pt) |
| CZ (1) | CZ391197A3 (pt) |
| HU (1) | HUP9802634A3 (pt) |
| IL (1) | IL118424A0 (pt) |
| NO (1) | NO975660L (pt) |
| PL (1) | PL324026A1 (pt) |
| SK (1) | SK168697A3 (pt) |
| TR (1) | TR199701536T1 (pt) |
| WO (1) | WO1996040122A1 (pt) |
| ZA (1) | ZA964373B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6177460B1 (en) | 1995-04-12 | 2001-01-23 | The Procter & Gamble Company | Method of treatment for cancer or viral infections |
| US6262093B1 (en) | 1995-04-12 | 2001-07-17 | The Proctor & Gamble Company | Methods of treating cancer with benzimidazoles |
| US6479526B1 (en) | 1995-04-12 | 2002-11-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| US5770616A (en) | 1995-06-07 | 1998-06-23 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
| US6265427B1 (en) | 1995-06-07 | 2001-07-24 | The Proctor & Gamble Company | Pharmaceutical composition for the method of treating leukemia |
| US6686391B2 (en) | 1995-08-04 | 2004-02-03 | University Of Arizona Foundation | N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions |
| US5900429A (en) | 1997-01-28 | 1999-05-04 | The Procter & Gamble Company | Method for inhibiting the growth of cancers |
| US6506783B1 (en) | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
| US6245789B1 (en) | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment |
| US6423734B1 (en) | 1999-08-13 | 2002-07-23 | The Procter & Gamble Company | Method of preventing cancer |
| US6380232B1 (en) | 2000-09-26 | 2002-04-30 | The Procter & Gamble Company | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
| US6407105B1 (en) | 2000-09-26 | 2002-06-18 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US6608096B1 (en) | 2000-09-26 | 2003-08-19 | University Of Arizona Foundation | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US6462062B1 (en) | 2000-09-26 | 2002-10-08 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| EP2251010A1 (en) | 2009-05-08 | 2010-11-17 | Sygnis Bioscience GmbH & Co. KG | Use of thiabendazole and derivatives thereof for the therapy of neurological conditions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL134354C (pt) * | 1963-05-23 | |||
| FR2155888A1 (en) * | 1971-10-13 | 1973-05-25 | Agot Aime | Solid anthelmintic composn - for more economical treatment of ruminants |
| NZ305784A (en) * | 1995-04-12 | 2001-03-30 | Procter & Gamble | Benzimidazole containing medicaments for treating cancers, tumors and viral infections |
-
1996
- 1996-05-22 CZ CZ973911A patent/CZ391197A3/cs unknown
- 1996-05-22 AU AU58020/96A patent/AU717382B2/en not_active Ceased
- 1996-05-22 CA CA002223435A patent/CA2223435A1/en not_active Abandoned
- 1996-05-22 JP JP9500667A patent/JPH11506732A/ja active Pending
- 1996-05-22 TR TR97/01536T patent/TR199701536T1/xx unknown
- 1996-05-22 PL PL96324026A patent/PL324026A1/xx unknown
- 1996-05-22 BR BR9608730A patent/BR9608730A/pt not_active Application Discontinuation
- 1996-05-22 HU HU9802634A patent/HUP9802634A3/hu unknown
- 1996-05-22 SK SK1686-97A patent/SK168697A3/sk unknown
- 1996-05-22 WO PCT/US1996/007445 patent/WO1996040122A1/en not_active Ceased
- 1996-05-22 KR KR1019970709098A patent/KR19990022617A/ko not_active Ceased
- 1996-05-22 CN CN96194465A patent/CN1186433A/zh active Pending
- 1996-05-22 EP EP96914749A patent/EP0831816A1/en not_active Withdrawn
- 1996-05-27 IL IL11842496A patent/IL118424A0/xx unknown
- 1996-05-29 ZA ZA964373A patent/ZA964373B/xx unknown
- 1996-06-07 AR ARP960103043A patent/AR003137A1/es not_active Application Discontinuation
-
1997
- 1997-12-05 NO NO975660A patent/NO975660L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11506732A (ja) | 1999-06-15 |
| IL118424A0 (en) | 1996-09-12 |
| KR19990022617A (ko) | 1999-03-25 |
| PL324026A1 (en) | 1998-05-11 |
| HUP9802634A3 (en) | 1999-05-28 |
| CZ391197A3 (cs) | 1998-05-13 |
| AU5802096A (en) | 1996-12-30 |
| EP0831816A1 (en) | 1998-04-01 |
| CA2223435A1 (en) | 1996-12-19 |
| ZA964373B (en) | 1996-09-02 |
| BR9608730A (pt) | 1999-06-29 |
| CN1186433A (zh) | 1998-07-01 |
| HUP9802634A2 (hu) | 1999-03-29 |
| SK168697A3 (en) | 1998-12-02 |
| WO1996040122A1 (en) | 1996-12-19 |
| NO975660L (no) | 1998-02-09 |
| NO975660D0 (no) | 1997-12-05 |
| TR199701536T1 (xx) | 1998-02-21 |
| AU717382B2 (en) | 2000-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR003137A1 (es) | Una composicion farmaceutica para tratar la leucemia | |
| ES2082805T3 (es) | Derivados de tiazol, procedimientos para su produccion y composiciones farmaceuticas que comprenden los mismos. | |
| TW427887B (en) | Pharmaceutical composition comprising a benzimidazole derivative for treating viral infections | |
| DE69830504D1 (de) | Antithrombotische mitteln | |
| ATE306261T1 (de) | Antithrombosemittel | |
| MY119150A (en) | Azetidine derivatives, their preparation and medicaments containing them | |
| AR029216A1 (es) | Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento | |
| PT97710A (pt) | Processo para a preparacao de novos derivados da amino-piperidina,da amino-pirrolidina e de amino-per-hidroazepina | |
| DE69528005D1 (de) | Prolineamid-Derivate | |
| ES2137169T3 (es) | Nuevos derivados de tiazolilbenzofurano, procedimientos para su preparacion y composicion farmaceutica que los contiene. | |
| RU94036772A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования эндометриоза | |
| ATE226574T1 (de) | 4,6-diarylpyrimidin-derivate und deren salze | |
| IL110151A0 (en) | Amide and urea derivatives and pharmaceutical compositions containing the same | |
| AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
| BR9201854A (pt) | Composto derivado de pridazinas,processo para sua preparacao,e,composicao farmaceutica | |
| CO5200778A1 (es) | Composicion farmaceutica que comprende una cantidad terapeuticamente efectiva de b enzimidazol, administrada para prevenir y tratar el cancer e inhibir la metastasis | |
| ES2060173T3 (es) | Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas. | |
| YU48089B (sh) | Novi derivati tetrazola i postupak za njihovo pripremanje | |
| RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
| AR002749A1 (es) | Derivados de estiril bencimidazol y composicion farmaceutica que los comprende. | |
| ES2191763T3 (es) | Inhibidor del desarrollo de dependencia/tolerancia a un agente analgesico narcotico. | |
| AR018675A1 (es) | Derivados de 3-(2-oxo-[1,3¿i¿]bipirrolidinil-3-ilidenometil)-cefem, una composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento. | |
| ES2178382T3 (es) | Compuestos de benciloxiprodigiosina. | |
| AR027035A1 (es) | Pirroles sustituidos | |
| ATE172959T1 (de) | Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |